Effects of dehydroepiandrosterone on proliferation and differentiation of chromaffin progenitor cells

Molecular and Cellular Endocrinology

Volumn 336, Issue 1-2, 2011, Pages 141-148

  Chung, Kuei Fang ^a   Qin, Nan ^a   Androutsellis Theotokis, Andreas ^a   Bornstein, Stefan R ^a   Ehrhart Bornstein, Monika ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Adrenal gland; Bone morphogenesis protein 4; Chromaffin progenitor cell; Dehydroepiandrosterone; Retinoic acid

Indexed keywords

DOPAMINE; DOPAMINE BETA MONOOXYGENASE; PRASTERONE; RETINOIC ACID; TYROSINE 3 MONOOXYGENASE;

ADRENAL MEDULLA; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMAFFIN CELL; CHROMAFFIN PROGENITOR CELL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE EXPRESSION; HORMONE ACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ANIMALS; BONE MORPHOGENETIC PROTEIN 4; CATTLE; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHROMAFFIN CELLS; DEHYDROEPIANDROSTERONE; DRUG SYNERGISM; GENE EXPRESSION REGULATION; NOREPINEPHRINE; RNA, MESSENGER; STEM CELLS; TRETINOIN;

EID: 79952070823     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.11.028     Document Type: Article

References (58)

1. Azizi H., Mehrjardi N.Z., Shahbazi E., Hemmesi K., Bahmani M.K., Baharvand H. Dehydroepiandrosterone stimulates neurogenesis in mouse embryonal carcinoma cell- and human embryonic stem cell-derived neural progenitors and induces dopaminergic neurons. Stem Cells Dev. 2010, 19:809-818.
2. Bornstein S.R., Ehrhart-Bornstein M., Usadel H., Bockmann M., Scherbaum W.A. Morphological evidence for a close interaction of chromaffin cells with cortical cells within the adrenal gland. Cell Tissue Res. 1991, 265:1-9.
3. Bottner A., Haidan A., Eisenhofer G., Kristensen K., Castle A.L., Scherbaum W.A., Schneider H., Chrousos G.P., Bornstein S.R. Increased body fat mass and suppression of circulating leptin levels in response to hypersecretion of epinephrine in phenylethanolamine-N-methyltransferase (PNMT)-overexpressing mice. Endocrinology 2000, 141:4239-4246.
4. Bornstein S.R., Engeland W.C., Ehrhart-Bornstein M., Herman J.P. Dissociation of ACTH and glucocorticoids. Trends Endocrinol. Metab. 2008, 19:175-180.
5. Charalampopoulos I., Dermitzaki E., Vardouli L., Tsatsanis C., Stournaras C., Margioris A.N., Gravanis A. Dehydroepiandrosterone sulfate and allopregnanolone directly stimulate catecholamine production via induction of tyrosine hydroxylase and secretion by affecting actin polymerization. Endocrinology 2005, 146:3309-3318.
6. Charalampopoulos I., Tsatsanis C., Dermitzaki E., Alexaki V.I., Castanas E., Margioris A.N., Gravanis A. Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteins. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8209-8214.
7. Chen L., He D.M., Zhang Y. The differentiation of human placenta-derived mesenchymal stem cells into dopaminergic cells in vitro. Cell. Mol. Biol. Lett. 2009, 14:528-536.
8. Chung K.F., Sicard F., Vukicevic V., Hermann A., Storch A., Huttner W.B., Bornstein S.R., Ehrhart-Bornstein M. Isolation of neural crest derived chromaffin progenitors from adult adrenal medulla. Stem Cells 2009, 27:2602-2613.
9. Cosgaya J.M., Garcia-Villalba P., Perona R., Aranda A. Comparison of the effects of retinoic acid and nerve growth factor on PC12 cell proliferation, differentiation, and gene expression. J. Neurochem. 1996, 66:89-98.
10. de Peretti E., Forest M.G. Unconjugated dehydroepiandrosterone plasma levels in normal subjects from birth to adolescence in human: the use of a sensitive radioimmunoassay. J. Clin. Endocrinol. Metab. 1976, 43:982-991.
11. Drucker-Colin R., Verdugo-Diaz L. Cell transplantation for Parkinson's disease: present status. Cell. Mol. Neurobiol. 2004, 24:301-316.
12. Ehrhart-Bornstein M., Hinson J.P., Bornstein S.R., Scherbaum W.A., Vinson G.P. Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocr. Rev. 1998, 19:101-143.
13. Ehrhart-Bornstein M., Chung K.F., Vukicevic V., Bornstein S.R. Is there a role for chromaffin progenitor cells in neurodegenerative diseases?. Mol. Psychiatry 2009, 14:1-4.
14. Ehrhart-Bornstein, M., Vukicevic, V., Chung, K.F., Ahmad, M., Bornstein, S.R., in press. Chromaffin progenitor cells from the adrenal medulla. Cell. Mol. Neurobiol. 2010 Nov 16. [Epub ahead of print].
15. Eisenhofer G., Goldstein D.S., Stull R., Keiser H.R., Sunderland T., Murphy D.L., Kopin I.J. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin. Chem. 1986, 32:2030-2033.
16. Fernandez-Espejo E., Armengol J.A., Flores J.A., Galan-Rodriguez B., Ramiro S. Cells of the sympathoadrenal lineage: biological properties as donor tissue for cell-replacement therapies for Parkinson's disease. Brain Res. Brain Res. Rev. 2005, 49:343-354.
17. Guan K., Chang H., Rolletschek A., Wobus A.M. Embryonic stem cell-derived neurogenesis. Retinoic acid induction and lineage selection of neuronal cells. Cell Tissue Res. 2001, 305:171-176.
18. Hiller, M., Liu, C.F., Blumenthal, P.D., Gearhart, J., Kerr, C., in press. Bone morphogenetic protein 4 mediates human embryonic germ cell derivation. Stem Cells Dev. 2010 Oct 21. [Epub ahead of print].
19. Hinson J.P., Khan M. Dehydroepiandrosterone sulphate (DHEAS) inhibits growth of human vascular endothelial cells. Endocr. Res. 2004, 30:667-671.
20. Huber K., Franke A., Bruhl B., Krispin S., Ernsberger U., Schober A., von Bohlen und Halbach O., Rohrer H., Kalcheim C., Unsicker K. Persistent expression of BMP-4 in embryonic chick adrenal cortical cells and its role in chromaffin cell development. Neural Dev. 2008, 3:28.
21. Ii M., Hoshiga M., Negoro N., Fukui R., Nakakoji T., Kohbayashi E., Shibata N., Furutama D., Ishihara T., Hanafusa T., Losordo D.W., Ohsawa N. Adrenal androgen dehydroepiandrosterone sulfate inhibits vascular remodeling following arterial injury. Atherosclerosis 2009, 206:77-85.
22. Jones-Villeneuve E.M., McBurney M.W., Rogers K.A., Kalnins V.I. Retinoic acid induces embryonal carcinoma cells to differentiate into neurons and glial cells. J. Cell Biol. 1982, 94:253-262.
23. Karishma K.K., Herbert J. Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur. J. Neurosci. 2002, 16:445-453.
24. Kimonides V.G., Khatibi N.H., Svendsen C.N., Sofroniew M.V., Herbert J. Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:1852-1857.
25. Kroboth P.D., Salek F.S., Pittenger A.L., Fabian T.J., Frye R.F. DHEA and DHEA-S: a review. J. Clin. Pharmacol. 1999, 39:327-348.
26. Krug A.W., Langbein H., Ziegler C.G., Bornstein S.R., Eisenhofer G., Ehrhart-Bornstein M. Dehydroepiandrosterone-sulphate (DHEA-S) promotes neuroendocrine differentiation of chromaffin pheochromocytoma PC12 cells. Mol. Cell. Endocrinol. 2009, 300:126-131.
27. Kumar M., Bagchi B., Gupta S.K., Meena A.S., Gressens P., Mani S. Neurospheres derived from human embryoid bodies treated with retinoic Acid show an increase in nestin and ngn2 expression that correlates with the proportion of tyrosine hydroxylase-positive cells. Stem Cells Dev. 2007, 16:667-681.
28. Kvetnansky R., Sabban E.L., Palkovits M. Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol. Rev. 2009, 89:535-606.
29. Labrie F., Belanger A., Cusan L., Gomez J.L., Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J. Clin. Endocrinol. Metab. 1997, 82:2396-2402.
30. Lea-Currie Y.R., Wen P., McIntosh M.K. Dehydroepiandrosterone reduces proliferation and differentiation of 3T3-L1 preadipocytes. Biochem. Biophys. Res. Commun. 1998, 248:497-504.
31. Lenders J.W., Eisenhofer G., Armando I., Keiser H.R., Goldstein D.S., Kopin I.J. Determination of metanephrines in plasma by liquid chromatography with electrochemical detection. Clin. Chem. 1993, 39:97-103.
32. Liu D., Iruthayanathan M., Homan L.L., Wang Y., Yang L., Wang Y., Dillon J.S. Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms. Endocrinology 2008, 149:889-898.
33. Liu H., Margiotta J.F., Howard M.J. BMP4 supports noradrenergic differentiation by a PKA-dependent mechanism. Dev. Biol. 2005, 286:521-536.
34. Liu P.S., Lin M.K., Hsieh H.L. Dehydroepiandrosterone sulfate inhibition of catecholamine secretion from bovine adrenal chromaffin cells. Neurosci. Lett. 1996, 204:181-184.
35. Madrazo I., Drucker-Colin R., Diaz V., Martinez-Mata J., Torres C., Becerril J.J. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson's disease. N. Engl. J. Med. 1987, 316:831-834.
36. Majewska M.D., Demirgoren S., Spivak C.E., London E.D. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Res. 1990, 526:143-146.
37. Merke D.P., Chrousos G.P., Eisenhofer G., Weise M., Keil M.F., Rogol A.D., Van Wyk J.J., Bornstein S.R. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency. N. Engl. J. Med. 2000, 343:1362-1368.
38. Merke D.P., Bornstein S.R., Avila N.A., Chrousos G.P. NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann. Intern. Med. 2002, 136:320-334.
39. McIntosh M., Hausman D., Martin R., Hausman G. Dehydroepiandrosterone attenuates preadipocyte growth in primary cultures of stromal-vascular cells. Am. J. Physiol. 1998, 275:E285-293.
40. Pinnock S.B., Lazic S.E., Wong H.T., Wong I.H., Herbert J. Synergistic effects of dehydroepiandrosterone and fluoxetine on proliferation of progenitor cells in the dentate gyrus of the adult male rat. Neuroscience 2009, 158:1644-1651.
41. Quinn N.P. The clinical application of cell grafting techniques in patients with Parkinson's disease. Prog. Brain Res. 1990, 82:619-625.
42. Rainey W.E., Carr B.R., Sasano H., Suzuki T., Mason J.I. Dissecting human adrenal androgen production. Trends Endocrinol. Metab. 2002, 13:234-239.
43. Reissmann E., Ernsberger U., Francis-West P.H., Rueger D., Brickell P.M., Rohrer H. Involvement of bone morphogenetic protein-4 and bone morphogenetic protein-7 in the differentiation of the adrenergic phenotype in developing sympathetic neurons. Development 1996, 122:2079-2088.
44. Riaz S.S., Theofilopoulos S., Jauniaux E., Stern G.M., Bradford H.F. The differentiation potential of human foetal neuronal progenitor cells in vitro. Brain Res. Dev. Brain Res. 2004, 153:39-51.
45. Rodriguez A., Muller D.C., Metter E.J., Maggio M., Harman S.M., Blackman M.R., Andres R. Aging, androgens, and the metabolic syndrome in a longitudinal study of aging. J. Clin. Endocrinol. Metab. 2007, 92:3568-3572.
46. Shi F., Corrales C.E., Liberman M.C., Edge A.S. BMP4 induction of sensory neurons from human embryonic stem cells and reinnervation of sensory epithelium. Eur. J. Neurosci. 2007, 26:3016-3023.
47. Shiri E.H., Mehrjardi N.Z., Tavallaei M., Ashtiani S.K., Baharvand H. Neurogenic and mitotic effects of dehydroepiandrosterone on neuronal-competent marrow mesenchymal stem cells. Int. J. Dev. Biol. 2009, 53:579-584.
48. Sicard F., Ehrhart-Bornstein M., Corbeil D., Sperber S., Krug A.W., Ziegler C.G., Rettori V., McCann S.M., Bornstein S.R. Age-dependent regulation of chromaffin cell proliferation by growth factors, dehydroepiandrosterone (DHEA), and DHEA sulfate. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:2007-2012.
49. Silvagno F., Guarnieri V., Capizzi A., Pescarmona G.P. Synergistic effect of retinoic acid and dehydroepiandrosterone on differentiation of human neuroblastoma cells. FEBS Lett. 2002, 532:153-158.
50. Sorensen D.B., Johnsen P.F., Bibby B.M., Bottner A., Bornstein S.R., Eisenhofer G., Pacak K., Hansen A.K. PNMT transgenic mice have an aggressive phenotype. Horm. Metab. Res. 2005, 37:159-163.
51. Suzuki M., Wright L.S., Marwah P., Lardy H.A., Svendsen C.N. Mitotic and neurogenic effects of dehydroepiandrosterone (DHEA) on human neural stem cell cultures derived from the fetal cortex. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:3202-3207.
52. Tremblay R.G., Sikorska M., Sandhu J.K., Lanthier P., Ribecco-Lutkiewicz M., Bani-Yaghoub M. Differentiation of mouse Neuro 2A cells into dopamine neurons. J. Neurosci. Methods 2010, 186:60-67.
53. Unsicker K., Huber K., Schutz G., Kalcheim C. The chromaffin cell and its development. Neurochem. Res. 2005, 30:921-925.
54. Unsicker K., Krisch B., Otten U., Thoenen H. Nerve growth factor-induced fiber outgrowth from isolated rat adrenal chromaffin cells: impairment by glucocorticoids. Proc. Natl. Acad. Sci. U.S.A. 1978, 75:3498-3502.
55. Williams M.R., Dawood T., Ling S., Dai A., Lew R., Myles K., Funder J.W., Sudhir K., Komesaroff P.A. Dehydroepiandrosterone increases endothelial cell proliferation in vitro and improves endothelial function in vivo by mechanisms independent of androgen and estrogen receptors. J. Clin. Endocrinol. Metab. 2004, 89:4708-4715.
56. Woolcott C.G., Shvetsov Y.B., Stanczyk F.Z., Wilkens L.R., White K.K., Caberto C., Henderson B.E., Le Marchand L., Kolonel L.N., Goodman M.T. Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study. Endocr. Relat. Cancer 2010, 17:125-134.
57. Yoneyama A., Kamiya Y., Kawaguchi M., Fujinami T. Effects of dehydroepiandrosterone on proliferation of human aortic smooth muscle cells. Life Sci. 1997, 60:833-838.
58. Ziegler C.G., Sicard F., Lattke P., Bornstein S.R., Ehrhart-Bornstein M., Krug A.W. Dehydroepiandrosterone induces a neuroendocrine phenotype in nerve growth factor-stimulated chromaffin pheochromocytoma PC12 cells. Endocrinology 2008, 149:320-328.